Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 5, 2013
Vascular fibrosis in atherosclerosisTao-Hua Lan, Xiong-Qing Huang, Hong-Mei Tan
Evidence-Based Complementary and Alternative Medicine : Ecam|June 5, 2018
Systems Pharmacology Dissection of Traditional Chinese Medicine Wen-Dan Decoction for Treatment of Cardiovascular DiseasesTao-Hua Lan, Lu-Lu Zhang, Yong-Hua Wang, et al.
Chinese Journal of Integrative Medicine|May 16, 2024
Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE-/- MiceXiao-Min Ou, Jing Cai, Xiao-Yue Hu, et al.
Chinese Journal of Integrative Medicine|September 17, 2021
Regulatory T Cells: A New Target of Chinese Medicine in Treatment of AtherosclerosisZhao-Ying Liang, Cai-Wen Qian, Tao-Hua Lan, et al.
Biochemical Pharmacology|April 26, 2011
Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibitionTao-Hua Lan, Zhi-Wei Xu, Zhi Wang, et al.
Scientific Reports|October 14, 2017
Ginsenoside Rb1 prevents homocysteine-induced EPC dysfunction via VEGF/p38MAPK and SDF-1/CXCR4 activationTao-Hua Lan, Dan-Ping Xu, Man-Ting Huang, et al.
Chinese Journal of Integrative Medicine|June 12, 2015
Effect of Shenzhu Guanxin Recipe () on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trialDan-Ping Xu, Huan-Lin Wu, Tao-Hua Lan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 3, 2023
XinLi formula, a traditional Chinese decoction, alleviates chronic heart failure via regulating the interaction of AGTR1 and AQP1Xiao-Hong Wei, Wen-Jing Liu, Wei Jiang, et al.
Forschende Komplementarmedizin (2006)|January 17, 2015
Efficacy and safety of Huxin formula in patients after CABG: a multicenter, double-blind, randomized clinical trialYu Lin, Yun-Fei Wang, Dong-Qun Lin, et al.
European Journal of Pharmacology|April 18, 2018
3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in ratsTao-Hua Lan, Xiao-Ling Chen, Yun-Shan Wu, et al.
Pageof 2